Pfizer has historically been among Direct Relief’s key partners in the donation of Rx medicines, including the distribution partner for its Diflucan Partnership Program that has supported millions of patients in Africa with opportunistic infections from HIV/ AIDS. In addition, Direct Relief has a strategic collaboration with Pfizer that is providing over 1 million doses of opioid overdose-reversing naloxone to American health centers through the Naloxone Access Program.
Pfizer and the Pfizer Foundation have provided significant financial support to Direct Relief, including during times of disaster and emergencies in the United States and around the world, as well as an initiative around infectious diseases in supporting US safety net provider health centers and clinics. For COVID-19, Pfizer has provided tens of thousands of units of much needed antibiotics and vasopressor therapies for Direct Relief’s COVID-19 ICU Rx Modules that are endorsed by the Society of Critical Care Medicine (SCCM), which enabled many thousands of hospitalized patients with serious COVID-19 infections to receive treatment for pneumonia infections and or septic shock.
The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc with distinct legal restrictions.